| Participants and study decliners’ perspectives about the risks of participating in a clinical trial of whole genome sequencing JO Robinson, TM Carroll, LZ Feuerman, DL Perry, L Hoffman-Andrews, ... Journal of Empirical Research on Human Research Ethics 11 (1), 21-30, 2016 | 55 | 2016 |
| Tumor monocyte content predicts immunochemotherapy outcomes in esophageal adenocarcinoma TM Carroll, JA Chadwick, RP Owen, MJ White, J Kaplinsky, I Peneva, ... Cancer Cell 41 (7), 1222-1241. e7, 2023 | 18 | 2023 |
| Hedgehog signaling inhibitors fail to reduce Merkel cell carcinoma viability TM Carroll, JS Williams, K Daily, T Rogers, T Gelb, A Coxon, SQ Wang, ... The Journal of investigative dermatology 137 (5), 1187, 2017 | 9 | 2017 |
| Limited effect of indolamine 2, 3-dioxygenase expression and enzymatic activity on lupus-like disease in B6. Nba2 mice LM Davison, JC Liu, L Huang, TM Carroll, AL Mellor, TN Jorgensen Frontiers in immunology 10, 2019 | 6 | 2019 |
| Mutant Ras and inflammation-driven skin tumorigenesis is suppressed via a JNK-iASPP-AP1 axis K Al Moussawi, K Chung, TM Carroll, C Osterburg, A Smirnov, R Lotz, ... Cell Reports 41 (3), 2022 | 5 | 2022 |
| p53 inhibitor iASPP is an unexpected suppressor of KRAS and inflammation-driven pancreatic cancer P Miller, EH Akama-Garren, RP Owen, C Demetriou, TM Carroll, E Slee, ... Cell Death & Differentiation 30 (7), 1619-1635, 2023 | 4 | 2023 |
| Regulation of immunological tolerance by the p53-inhibitor iASPP EH Akama-Garren, P Miller, TM Carroll, M Tellier, G Sutendra, L Buti, ... Cell Death & Disease 14 (2), 84, 2023 | 3 | 2023 |
| Multiscale methods for signal selection in single-cell data RS Hoekzema, L Marsh, O Sumray, TM Carroll, X Lu, HM Byrne, ... Entropy 24 (8), 1116, 2022 | 3 | 2022 |
| 1-D-Methyl tryptophan treatment of lupus-prone B6. Nba2 mice reduces antinuclear autoantibody levels and B cell differentiation (THER5P. 837) L Davison, T Carroll, R Gurion, A Mellor, T Jorgensen The Journal of Immunology 192 (1_Supplement), 200.16-200.16, 2014 | 1 | 2014 |
| Abstract CT208: High tumor monocyte content predicts long-term survival for patients with operable oesophageal cancer treated with neoadjuvant immunochemotherapy in the LUD2015 … HS Fuchs, SA James, TM Carroll, PF Xie, JA Chadwick, D Parkes, ... Cancer Research 84 (7_Supplement), CT208-CT208, 2024 | | 2024 |
| Abstract LB131: Association between epigenetic heterogeneity of esophageal adenocarcinoma and response to first-line immunochemotherapy in LUD2015-005 Trial PF Xie, J Chang, P Siejka-Zielińska, M Inoue, M Drożdż, JA Chadwick, ... Cancer Research 83 (8_Supplement), LB131-LB131, 2023 | | 2023 |
| Comprehensive molecular profiling to predict first-line immunochemotherapy outcomes in inoperable esophageal adenocarcinoma TM Carroll, JA Chadwick, RP Owen, MJ White, J Kaplinsky, I Peneva, ... Cancer Research 82 (12_Supplement), 1247-1247, 2022 | | 2022 |
| Predicting and understanding outcomes on first-line immunochemotherapy for oesophageal adenocarcinoma: Deep molecular profiling of the LUD2015-005 trial T Carroll University of Oxford, 2021 | | 2021 |
